HYPERVOLAEMIA side effect
What is HYPERVOLAEMIA ?HYPERVOLAEMIA : Ambrisentan Side Effects Report #5385897-3
Consumer or non-health professional from UNITED STATES reported AMBRISENTAN problem on July 02, 2007. Male patient, weighting 188.7 lb, was diagnosed with pulmonary hypertension, dyspnoea, prophylaxis, fluid retention and was treated with AMBRISENTAN. After drug was administered, patient experienced the following problems/side effects: hypervolaemia, right ventricular failure, . AMBRISENTAN dosage: unknown. During the same period patient was treated with DIGOXIN, ALBUTEROL, WARFARIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.
HYPERVOLAEMIA : Ambrisentan Side Effects Report #5385897-3
AMBRISENTAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Male patient, weighting 188.7 lb, was diagnosed with pulmonary hypertension, dyspnoea, prophylaxis, fluid retention and was treated with AMBRISENTAN. After drug was administered, patient experienced the following problems/side effects: hypervolaemia, right ventricular failure, . AMBRISENTAN dosage: unknown. During the same period patient was treated with DIGOXIN, ALBUTEROL, WARFARIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.
HYPERVOLAEMIA : Aranesp Side Effects Report #5396438-9
Physician from POLAND reported ARANESP problem on June 26, 2007. Female patient was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypertension, hypervolaemia, metabolic acidosis, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with METHYLDOPA. Patient recovered.
HYPERVOLAEMIA : Aranesp Side Effects Report #5396438-9
ARANESP problem was reported by a Physician from POLAND on June 26, 2007. Female patient was diagnosed with renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: hypertension, hypervolaemia, metabolic acidosis, therapeutic response decreased, . ARANESP dosage: unknown. During the same period patient was treated with METHYLDOPA. Patient recovered.
HYPERVOLAEMIA : Clofarabine Side Effects Report #5579999-6
Health Professional from UNITED STATES reported CLOFARABINE problem on Dec 27, 2007. Female patient, weighting 183.0 lb, was diagnosed with bone marrow transplant and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomegaly, hypervolaemia, pulmonary oedema, . CLOFARABINE dosage: 76MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.
HYPERVOLAEMIA : Ambrisentan Side Effects Report #5400988-6
AMBRISENTAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, weighting 269.0 lb, was diagnosed with pulmonary hypertension and was treated with AMBRISENTAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hepatic enzyme increased, hypervolaemia, right ventricular failure, . AMBRISENTAN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, SILDENAFIL CITRATE, WARFARIN, FUROSEMIDE, LISINOPRIL, DILTIAZEM, GLIPIZIDE, SALSALATE. Patient was hospitalized. Patient recovered.
HYPERVOLAEMIA : Ambrisentan Side Effects Report #5400988-6
Consumer or non-health professional from UNITED STATES reported AMBRISENTAN problem on July 20, 2007. Female patient, weighting 269.0 lb, was diagnosed with pulmonary hypertension and was treated with AMBRISENTAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hepatic enzyme increased, hypervolaemia, right ventricular failure, . AMBRISENTAN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, SILDENAFIL CITRATE, WARFARIN, FUROSEMIDE, LISINOPRIL, DILTIAZEM, GLIPIZIDE, SALSALATE. Patient was hospitalized. Patient recovered.